Caspofungin Population Pharmacokinetics in Critically Ill Patients Undergoing Continuous Veno-Venous Haemofiltration or Haemodiafiltration

Roger, C., Wallis, S.C., Muller, L., Saissi, G., Lipman, J., Bruggemann, R.J., Lefrant, J.-Y. and Roberts, J.A. (2016) Caspofungin Population Pharmacokinetics in Critically Ill Patients Undergoing Continuous Veno-Venous Haemofiltration or Haemodiafiltration. Clinical Pharmacokinetics, 56 9: 1-12. doi:10.1007/s40262-016-0495-z


Author Roger, C.
Wallis, S.C.
Muller, L.
Saissi, G.
Lipman, J.
Bruggemann, R.J.
Lefrant, J.-Y.
Roberts, J.A.
Title Caspofungin Population Pharmacokinetics in Critically Ill Patients Undergoing Continuous Veno-Venous Haemofiltration or Haemodiafiltration
Journal name Clinical Pharmacokinetics   Check publisher's open access policy
ISSN 1179-1926
0312-5963
Publication date 2016-12-29
Year available 2017
Sub-type Article (original research)
DOI 10.1007/s40262-016-0495-z
Open Access Status Not yet assessed
Volume 56
Issue 9
Start page 1
End page 12
Total pages 12
Place of publication Auckland, New Zealand
Publisher Springer International Publishing
Language eng
Subject 3004 Pharmacology
2736 Pharmacology (medical)
Abstract Background and Objective Sepsis and continuous renal replacement therapy (CRRT) can both significantly affect antifungal pharmacokinetics. This study aimed to describe the pharmacokinetics of caspofungin in critically ill patients during different CRRT modes.
Keyword Renal Replacement Therapy
Intensive-Care-Unit
Candida Spp.
Septic Shock
Multicenter
Infection
Outcomes
Pharmacodynamics
Anidulafungin
Echinocandins
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status UQ

 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in Thomson Reuters Web of Science Article
Scopus Citation Count Cited 0 times in Scopus Article
Google Scholar Search Google Scholar
Created: Mon, 16 Jan 2017, 22:13:03 EST by Matthew Lamb on behalf of Research Strategy and Support (Medicine)